Welcome to our dedicated page for ECOLAB SEC filings (Ticker: ECL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ecolab Inc. filings document the public-company disclosures of a Delaware operating company whose common stock trades on the New York Stock Exchange under ECL. The filings cover operating and financial results, supplemental segment reporting, changes to reportable segment structure, capital-structure information and material-event reports.
Proxy and 8-K filings describe annual-meeting matters, board and executive-leadership changes, compensation and governance topics, and shareholder voting materials. Other disclosures address material agreements, restructuring and exit-cost matters associated with the One Ecolab initiative, business context for water, hygiene and infection prevention operations, and the company’s service footprint across multiple customer industries.
Ecolab Inc. director John J. Zillmer reported a new grant of non-employee director stock options. He received 732 options for Common Stock at an exercise price of $247.70 per share, expiring on May 15, 2036.
The options vest in stages: 25% of the shares at the end of each of the first three three‑month periods after the grant date, with the remaining shares vesting on the earlier of the end of the fourth three‑month period or the company’s next annual meeting. After this filing, he directly holds 49,191.86 Common shares and 732 options.
Ecolab Inc. director Julie Whalen reported new equity awards in the form of non-employee director stock options. She received two option grants covering a total of 1,269 shares of common stock at an exercise price of $247.70 per share, with staged vesting over four three-month periods and full acceleration upon a qualifying change in control. Following these awards, she also reports direct ownership of 341.03 shares of common stock.
Vautrinot Suzanne M reported acquisition or exercise transactions in this Form 4 filing.
Ecolab Inc. director Suzanne M. Vautrinot received a grant of 732 Non-Employee Director Stock Options to buy common stock at $247.70 per share. The options vest 25% at the end of each of the first three three-month periods after grant, with the remainder vesting earlier of the fourth three-month period’s end or the next annual meeting, and they fully vest upon a defined Change in Control. Following these transactions, she holds 11,651.22 common shares directly and 732 options.
Ecolab Inc. director Lionel L. Nowell III reported a routine compensation-related equity award. He received 732 Non-Employee Director stock options, each giving the right to buy one share of common stock at an exercise price of $247.70 and expiring on May 15, 2036.
The options vest in four steps: 25% on each of the last days of the first three three‑month periods after the grant, with the remaining shares vesting on the earlier of the last day of the fourth three‑month period or the company’s next annual meeting. The footnote states all options become fully exercisable if a defined Change in Control occurs. Following these updates, Nowell directly holds 6,625.38 shares of Ecolab common stock.
Ecolab Inc. director Tracy B. McKibben received a new stock option award covering 732 shares of common stock. The non-employee director option has an exercise price of $247.7000 per share and is scheduled to expire on May 15, 2036.
According to the vesting terms, the option becomes exercisable in four installments: 25% of the shares on the last day of each of the first, second and third three-month periods after the grant date, and the remaining shares on the earlier of the last day of the fourth three‑month period or the company’s next annual meeting date. The option becomes fully exercisable immediately if a Change in Control, as defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan, occurs. Following this filing, McKibben directly holds 11,515.9600 shares of Ecolab common stock.
Ecolab Inc. director David MacLennan reported an equity compensation update. He received a grant of 732 Non-Employee Director Stock Options, each with an exercise price of $247.70 per share, linked to Ecolab common stock.
The options vest in stages: 25% of the shares on the last day of each of the first three three-month periods after the grant date, with the remaining shares vesting on the earlier of the last day of the fourth three-month period or the company’s next annual meeting date. The options become fully exercisable immediately if a defined Change in Control occurs.
After this report, MacLennan is shown with 25,230.01 Ecolab common shares held directly, plus indirect holdings of 3,500 shares through the Kathleen F. MacLennan Revocable Trust and 709 shares through sibling trusts.
Ecolab Inc. director Michael Larson received a grant of 732 Non-Employee Director Stock Options linked to 732 shares of common stock. The options have an exercise price of $247.7000 per share and expire on May 15, 2036. They vest 25% at the end of each of the first three three-month periods after the grant date, with the remaining shares vesting on the earlier of the end of the fourth three-month period or the company’s next annual meeting. The options become fully exercisable if a Change in Control occurs. Following these transactions, Larson directly holds 19,007.5 shares of Ecolab common stock.
Ecolab Inc. director Marion K. Gross reported a new grant of non-employee director stock options. She received options for 732 shares of common stock at an exercise price of $247.70 per share, expiring on May 15, 2036.
The options begin vesting on August 15, 2026, with 25% of the shares vesting at the end of each of the first three three-month periods after grant and the remainder vesting on the earlier of the end of the fourth three-month period or the company’s next annual meeting. The filing also shows she directly holds 466.0100 shares of common stock after the reported transactions.
Ecolab Inc. director Eric Mark Green received a new stock option grant as part of his board compensation. He was awarded options for 732 shares of common stock at an exercise price of $247.7000 per share, with no cash paid at grant.
The options vest in stages: 25% of the shares on the last day of each of the first three three-month periods after the grant date, and the remaining shares on the earlier of the last day of the fourth three-month period or the company’s next annual meeting date. All options become fully exercisable if a defined Change in Control of the company occurs.
Following these updates, Green directly holds 3,973.5100 shares of Ecolab common stock and 732 stock options, reflecting routine equity-based compensation rather than an open-market purchase or sale.
ECOLAB INC. director Michel D. Doukeris reported a new stock option grant and updated share holdings. He received a grant of 732 Non-Employee Director Stock Options, each covering one share of Common Stock, with an exercise price of 247.7000 and expiration on 2036-05-15.
The option vests in stages: 25% of the option shares on the last day of each of the first three three‑month periods after the grant date, and the remaining shares on the last day of the fourth three‑month period or the company’s next annual meeting date, whichever is earlier. The first vesting date is listed as 2026-08-15.
Following these updates, Doukeris is shown holding 576.2600 shares of Ecolab Common Stock directly, and 732.0000 director stock options tied to an equal number of underlying Common Stock shares.